CNTA•benzinga•
Centessa Pharmaceuticals Announces Poster Presentation Of Phase 1 Clinical Data For ORX750, A Novel Orexin Receptor 2 Agonist, At The AAN 2025 Annual Meeting
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 6, 2025 by benzinga